"In May 2003, Easton led a $55.3 million financing for Acorda Therapeutics,
one of the top three private biotechnology financings to date in 2003. Easton's ability to lead
such a significant round, particularly in a challenging financial environment, is a testament to
its capabilities and excellence. Acorda's management and Board were thoroughly impressed by the
acumen and performance of the people at Easton. They comprise a rare mix of expertise in finance,
life sciences, business development and value creation, together with meticulous attention to detail
and passionate commitment. We are especially pleased that John Friedman has joined our Board of
Directors, where we expect his insights to contribute substantially to Acorda's future successes."
Ron Cohen
Founder, President, and CEO, Acorda Therapeutics
Coapt Systems, Inc.
Coapt is a Palo Alto based company
that designs, develops, manufactures, and markets bio absorbable
implants specifically to provide surgeons with the next generation of
soft tissue fixation technology. The Company has developed a
breakthrough platform technology for soft tissue fixation that enables
surgeons to reduce operating time, facilitate minimally invasive
procedures, minimize procedural complexity, and achieve improved
surgical outcomes. Easton led an investment in March 2007. Other
investors in the Company include Alta Partners, Canaan Partners, Boston
Millennia Partners and Global Life Science Ventures.